0.380
0.00 (-0.05%)
| Previous Close | 0.380 |
| Open | 0.358 |
| Volume | 10,779 |
| Avg. Volume (3M) | 322,454 |
| Market Cap | 13,064,802 |
| Price / Earnings (Forward) | 6.97 |
| Price / Sales | 585.78 |
| Price / Book | 227.66 |
| 52 Weeks Range |
| Diluted EPS (TTM) | -0.110 |
| Total Debt/Equity (MRQ) | 6.71% |
| Current Ratio (MRQ) | 1.91 |
| Operating Cash Flow (TTM) | -4.91 M |
| Levered Free Cash Flow (TTM) | -3.52 M |
| Return on Assets (TTM) | -99.87% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (US) | Bullish | Mixed |
| Biotechnology (Global) | Bullish | Mixed | |
| Stock | Jupiter Neurosciences, Inc. | - | - |
AIStockmoo Score
| Analyst Consensus | 2.0 |
| Insider Activity | NA |
| Price Volatility | 0.5 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -0.5 |
| Average | 0.50 |
|
Jupiter Neurosciences Inc is a clinical-stage research and development pharmaceutical company located in Jupiter, Florida. The company has developed a resveratrol platform product that targets the treatment of neuro-inflammation. Its platform product, JOTROL, offers potential therapeutic benefit to the majority of central nervous system diseases such as Alzheimer's disease, ataxias, and metabolic disorders such as Lysosomal Storage Disorders and mitochondrial diseases. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| % Held by Insiders | 57.50% |
| % Held by Institutions | 1.17% |
Ownership
| Name | Date | Shares Held |
|---|---|---|
| Allen Capital Group, Llc | 31 Dec 2025 | 30,000 |
| Vestor Capital, Llc | 31 Dec 2025 | 671 |
No data within this time range.
No data within this time range.
| Date | Type | Details |
|---|---|---|
| 28 Jan 2026 | Announcement | Jupiter Neurosciences Expands Nugevia™ Addressable Market with Focus on GLP-1 Users |
| 27 Jan 2026 | Announcement | Jupiter Neurosciences Presenting at the 3rd Annual DealFlow Discovery Conference |
| 23 Jan 2026 | Announcement | DealFlow Discovery Conference Announces Initial Lineup of Presenting Companies Ahead of Next Week's Event |
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2026 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |